Mereo BioPharma Group plc (MREO) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.30 +3.45%
Financial Fact:
Other general and administrative expenses: 74.75K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Other general and administrative expenses: 74.75K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Mereo BioPharma Group plc (NASDAQ: MREO) reported Q2 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Trump says U.S. and Denmark reached permanent security deal over Greenland
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
